1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 4, 1996, Pages 367-376

  Simboli Campbell, Maura ^a   Narvaez, Carmen J ^b   Tenniswood, Martin ^b   Welsh, JoEllen ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Adirondack Biomedical Research Institute Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CALCITRIOL; CATHEPSIN B; CLUSTERIN; DNA FRAGMENT; MESSENGER RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; CYTOCHEMISTRY; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; IN VITRO STUDY;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030200377     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00055-6     Document Type: Article

References (37)

1. 1. Chouvet C., Berger U. and Coombes R. C.: 1,25-Dihydroxyvitamin, D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J. Steroid Biochem. 24 (1986) 373-376.
2. 2. Eisman J., Sutherland R. L., McMenemy M. L., Fragonas J. C., Musgrove E. A. and Pang G.: Effects of 1,25-dihydroxyvitamin D3 on cell cycle kinetics of T47D human breast cancer cells. J. Cell. Physiol. 138 (1989) 611-616.
3. 3. Colston K., Chander S. K., Mackay A. G. and Coombes R. C.: Effects of synthetic vitamin D analogs on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol. 44 (1992) 693-702.
4. 3 analogues and tamoxifen. Cancer Res. 54 (1994) 5711-5717.
5. 5. Eisman J, A., Martin T. J., MacIntyre I. and Moseley J. M.: 1,25-Dihydroxyvitamin D3 receptors in breast cancer cells. Lancet ii (1979) 1335-1336.
6. 6. Buras R. R., Schumaker L. M., Davoodi F., Brenner R. V., Shabahang M., Nauta R. J. and Evans S. R. T.: Vitamin D receptors in breast cancer cells. Breast Cancer Res. Treat. 31 (1994) 191-202.
7. 7. Abe J., Nakano T., Nishii Y., Matsumoto T., Ogata E. and Ikeda K.: A novel vitamin D3 analog, 22-oxa-1,25 dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129 (1992) 832-837.
8. 8. Williams G. T.: Programmed cell death: apoptosis and oncogenesis. Cell 65 (1991) 1097-1098.
9. 9. Oberhammer F., Wilson J. W., Dive C., Morris I. D., Hickman J. A., Wakeling A. E., Walker P. R. and Sikorska M.: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal degradation. EMBO J. 12 (1993) 3679-3684.
10. 10. Cohen G. M., Sun X. M., Snowden R. T., Dinsdale D. and Skilleter D. N.: Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286 (1992) 331-334.
11. 11. Zakeri Z. F., Quaglino D., Latham T. and Lockshin R. A.: Delayed internucleosomal DNA fragmentation in programmed cell death. FASEB J. 7 (1993) 470-478.
12. 12. Tenniswood M., Guenette R. S., Lakins J., Mooibroek M., Wong P. and Welsh J. E.: Active cell death in hormone-dependent tissues. Cancer Metast. Rev. 11 (1992) 197-220.
13. 13. Tenniswood M. P., Taillefer D., Lakins: J., Guenette R. S., Mooibroek M., Daehlin L. and Welsh J. E.: Control of gene expression during apoptosis in hormone-dependent tissues. In Apoptosis: The Molecular Basis of Cell Death, Vol. II. (Edited by L. D. Tomei and F. O. Cope). Cold Spring Harbor Laboratory Press, NY (1994) pp. 283-311.
14. 14. Guenette R. S., Corbeil H., Leger J., Wong K., Mezl V., Mooibroek M. and Tenniswood M.: Induction of gene expression during involution of the lactating mammary gland of the rat. J. Molec. Endocr. 12 (1994) 47-60.
15. 15. Guenette R. S., Mooibroek M., Wong K., Wong P. and Tenniswood M.: Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. Eur. J. Biochem. 226 (1994) 311-321.
16. 3: coordinate regulator of active cell death and proliferation in MCF-7 breast cancer cells. In Schering Foundation Workshop, Vol. 14: Workshop on Apoptosis in Hormone-dependent Cancers, Springer Verlag, Berlin (1995) pp. 181-200.
17. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cells. Cancer Res. 55 (1995) 2822-2830.
18. 18. James S. Y., Mackay A. G. and Colston K.: Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J. Molec. Endocr. 14 (1995) 391-394.
19. 3 binding and calbindin D-28K in renal (MDBK) cells. Molec. Cell. Endocr. 83 (1992) 143-151.
20. 3 translocates PKCβ to nucleus, and enhances plasma membrane association of PKCα, in renal epithelial cells. J. Biol. Chem. 269 (1994) 3257-3264.
21. 21. Wong P., Taillefer D., Lakins J., Pineault J., Chader G. and Tenniswood M.: Molecular characterization of human TRPM-2/ clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur. J. Biochem. 221 (1994) 817-925.
22. 22. Pandey S., Walker P. R. and Sikorska M.: Separate pools of endonuclease activity are responsible for internucleosomal and high molecular mass DNA fragmentation during apoptosis. Biochem. Cell. Biol. 72 (1994) 625-629.
23. 23. Wang T. T. Y. and Phang J. M.: Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55 (1995) 2487-2489.
24. s sensitizes MCF-7 cells to chemotherapy induced apoptosis. Cancer Res. 55 (1995) 2507-2510.
25. 25. Miller T. E., Beausang L. A., Meneghini N. and Lidgard G.: Cell death and nuclear matrix proteins. In Apoptosis II: The Molecular Basis of Cell Death. Cold Spring Harbor Laboratory Press, NY (1994) pp. 357-376.
26. 26. Oberhammer F., Hochegger K., Froschl G., Tiefenbacher R. and Pavelka M.: Chromatin condensation during apoptosis is accompanied by degradation of lamin A + B, without enhanced activation of cdc2 kinase. J. Cell. Biol. 126 (1994) 827-837.
27. 27. Yang C. H., Lambie E. J. and Snyder M.: NUMA: an unusually long coiled-coil related protein in mammalian nucleus. J. Cell. Biol. 116 (1991) 1303-1317.
28. 28. Lanzerotti R. H. and Gullino P. M.: Activities and quantities of lysosomal enzymes during mammary tumor regression. Cancer Res. 32 (1972) 2679-2685.
29. 29. Kyprianou N., English H., Davidson N. and Isaacs J.: Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51 (1991) 162-166.
30. 30. Warri A. M., Huovinen R. L., Laine A. M., Martikainen P. M. and Harkonen P. L.: Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J. Natn. Cancer Inst. 85 (1993) 1412-1418.
31. 31. Urban J., Parczyk K., Leutz A., Kayne M. and Kondor-Kock C.: Constitutive apical secretion of an 80 kD sulfated glycoprotein complex in the polarized epithelial Madin Darby canine kidney cell line. J. Cell. Biol. 105 (1987) 2735-2743.
32. 32. Pilarsky C., Haase W. and Koch-Brandt C.: Stable expression of gp80 (TRPM-2, clusterin), a secretory protein implicated in programmed cell death, in transfected BHK-21 cells. Biochem. Biophys. Acta 1179 (1993) 306-310.
33. 3 resistant MCF-7 cell line. Endocrinology 137 (1996) 400-409.
34. 34. Bardon S., Vignon F., Montcourrier P. and Rochefort H.: Steroid mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res. 47 (1987) 1441-1448.
35. 35. Sloane B. F., Moin K., Sameni M., Tait L. R., Rozhin J. and Ziegler G.: Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J. Cell. Sci. 107 (1994) 373-384.
36. 36. Nemere I.: Vesicular calcium transport in chick intestine. J. Nutr. 122 (1991) 657-661.
37. 3 and E B1089 on cell cycle kinetics in MCF-7 cells. In Vitamin D. A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. (Edited by A. W. Norman, R. Bouillon and M. Thomasset). Walter de Gruyter and Co., Berlin (1994) pp. 506-507.